Added Value of SPECT/CT in Post Lu-177 Dotatate Treatment for Neuroendocrine Tumors

被引：0
|
作者：
Couch, Paige [1 ]
Webb, Chelsea [2 ]
Botkin, Crystal [1 ]
Frye, Sarah [1 ]
Muzaffar, Razi [2 ]
Osman, Medhat [2 ]
机构：
[1] St Louis Univ, Nucl Med Technol Program, Dept Clin Hlth Sci, Doisy Coll Hlth Sci, St Louis, MO 63103 USA
[2] St Louis Univ, Dept Radiol, Div Nucl Med, St Louis, MO 63103 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
2044
引用
收藏
页数：2
相关论文
共 50 条
  • [21] LU-177 DOTATATE THERAPY IN PATIENTS WITH NETS
    Hosking, E.
    McKay, E.
    Browne, E.
    Thomas, D.
    Liauw, W.
    Morris, D.
    Chu, F.
    Hayes, A.
    Butler, P.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 18 - 18
  • [22] Added value of post 177Lu Dotatate and Ga PET/CT imaging in prediction and evaluation of treatment response for GEP NETs
    Abenavoli, E. M.
    Linguanti, F.
    Briganti, V
    Antonuzzo, L.
    Mungai, F.
    Simontacchi, G.
    Vaggelli, L.
    Matteini, M.
    Lavacchi, D.
    Sciagra, R.
    Berti, V
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 173 - 173
  • [23] An international quantitative SPECT/CT imaging exercise for Lu-177
    Tran-Gia, J.
    Robinson, A. P.
    Calvert, N.
    Denis-Bacelar, A. M.
    Fenwick, A. J.
    Ferreira, K. M.
    Finocchiaro, D.
    Fioroni, F.
    Grassi, E.
    Heetun, W.
    Jewitt, S. J.
    Kalathas, T.
    Kotzasarlidou, M.
    Ljungberg, M.
    McGowan, D. R.
    Scuffham, J.
    Gleisner, K. Sjogreen
    Tipping, J.
    Wevrett, J.
    Lassmann, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S15 - S16
  • [24] Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with 177Lu-DOTATATE
    Roth, Daniel
    Gustafsson, Johan
    Warfvinge, Carl Fredrik
    Sundlov, Anna
    Akesson, Anna
    Tennvall, Jan
    Gleisner, Katarina Sjogreen
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (03) : 399 - 405
  • [25] Evaluation of thyroid function in patients receiving Lu-177 DOTATATE treatment
    Kibar, A.
    Ince, B.
    Nazari, A.
    Toplutas, K. N.
    Bilgic, S.
    Asa, S.
    Besli, R. L. Uslu
    Sager, M. S.
    Sayman, H. B.
    Sonmezoglu, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S470 - S470
  • [26] Treatment of neuroendocrine tumors (NETs) with combination of everolimus and lu-177 radiolabeled somatostatin analogue
    Aljubran, Ali Husain
    Tuli, Mahmoud
    Raef, Hussein
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [27] Quantitative SPECT/CT Metrics in Early Prediction of [177Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients
    Tuncer, Onur
    Steinberger, Daniel
    Steiner, Joseph
    Hinojos, Madeleine
    Rhee, Stephanie Y.
    Humphrey, Brad
    Jafari, Farhad
    Cayci, Zuzan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (10) : 1584 - 1590
  • [28] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Yeokyeong Shin
    Bo Hyun Moon
    Baek-Yeol Ryoo
    Heung-Moon Chang
    Kyu-pyo Kim
    Yong Sang Hong
    Tae Won Kim
    Jin-Sook Ryu
    Yong-il Kim
    Changhoon Yoo
    Targeted Oncology, 2024, 19 : 41 - 49
  • [29] Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
    Shin, Yeokyeong
    Moon, Bo Hyun
    Ryoo, Baek-Yeol
    Chang, Heung-Moon
    Kim, Kyu-pyo
    Hong, Yong Sang
    Kim, Tae Won
    Ryu, Jin-Sook
    Kim, Yong-il
    Yoo, Changhoon
    TARGETED ONCOLOGY, 2024, 19 (01) : 41 - 49
  • [30] Dosimetric studies of 177Lu-DOTATATE administered into neuroendocrine tumors
    Gupta, Santosh
    Singla, Suhas
    Chakraborty, Sudipta
    Banerjee, Sharmila
    Das, Tapas
    Venkatesh, Meera
    Bal, C.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
12345